BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 8282118)

  • 1. Brefeldin A blocks protein glycosylation and RNA replication of vesicular stomatitis virus.
    Irurzun A; Pérez L; Carrasco L
    FEBS Lett; 1993 Dec; 336(3):496-500. PubMed ID: 8282118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of membrane traffic in the replication of poliovirus genomes: effects of brefeldin A.
    Irurzun A; Perez L; Carrasco L
    Virology; 1992 Nov; 191(1):166-75. PubMed ID: 1329315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of vesicular stomatitis virus replication by delta 12-prostaglandin J2 is regulated at two separate levels and is associated with induction of stress protein synthesis.
    Pica F; De Marco A; De Cesare F; Santoro MG
    Antiviral Res; 1993 Mar; 20(3):193-208. PubMed ID: 8385894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Action of brefeldin A on translation in Semliki Forest virus-infected HeLa cells and cells doubly infected with poliovirus.
    Pérez L; Irurzun A; Carrasco L
    J Gen Virol; 1994 Sep; 75 ( Pt 9)():2197-203. PubMed ID: 8077919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of vesicular stomatitis virus multiplication in Vero cells by 2-deoxy-D-glucose.
    Sabina LR; Telasco CE
    Acta Virol; 1979 May; 23(3):210-20. PubMed ID: 41433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Streptovirudin inhibits glycosylation and multiplication of vesicular stomatitis virus.
    Kang MS; Park JJ; Singh I; Phillips LA
    Biochem Biophys Res Commun; 1981 Mar; 99(2):422-8. PubMed ID: 6263283
    [No Abstract]   [Full Text] [Related]  

  • 7. Vesicular stomatitis viruses resistant to the methylase inhibitor sinefungin upregulate RNA synthesis and reveal mutations that affect mRNA cap methylation.
    Li J; Chorba JS; Whelan SP
    J Virol; 2007 Apr; 81(8):4104-15. PubMed ID: 17301155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of transcriptase activity or transcription-inhibiting ability in defective interfering particles of vesicular stomatitis virus.
    Perrault J; Holland JJ
    Virology; 1972 Oct; 50(1):150-70. PubMed ID: 4343109
    [No Abstract]   [Full Text] [Related]  

  • 9. Release of low infectivity vesicular stomatitis virus particles from tunicamycin-treated cells.
    Maheshwari RK; Singh VK; Husain MM; Friedman RM; Mohanty SB
    J Exp Pathol; 1985; 2(3):149-63. PubMed ID: 3023584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the antiviral mechanisms of protein kinase inhibitors K-252a and KT5926 against the replication of vesicular stomatitis virus.
    Kim YS; Kawai A
    Biol Pharm Bull; 1998 May; 21(5):498-505. PubMed ID: 9635507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural selection of mutants of vesicular stomatitis virus by cultured cells of Drosophila melanogaster.
    Mudd JA; Leavitt RW; Kingsbury DT; Holland JJ
    J Gen Virol; 1973 Sep; 20(3):341-51. PubMed ID: 4355329
    [No Abstract]   [Full Text] [Related]  

  • 12. Production of vesicular stomatitis virus with low infectivity by interferon-treated cells.
    Maheshwari RK; Friedman RM
    J Gen Virol; 1979 Jul; 44(1):261-4. PubMed ID: 227998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of recombinant vesicular stomatitis viruses encoding mutant glycoproteins demonstrate a critical role for maintaining a high pH threshold for membrane fusion in viral fitness.
    Fredericksen BL; Whitt MA
    Virology; 1998 Jan; 240(2):349-58. PubMed ID: 9454708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Brefeldin A to localize block in intracellular transport of vesicular stomatitis virus G protein on interferon-treated cells.
    Polakova K; Russ G
    Arch Virol; 1992; 124(1-2):171-9. PubMed ID: 1373940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro synthesis of proteins by membrane-bound polyribosomes from vesicular stomatitis virus-infected HeLa cells.
    Grubman MJ; Ehrenfeld E; Summers DF
    J Virol; 1974 Sep; 14(3):560-71. PubMed ID: 4368799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of interferon treatment on vesicular stomatitis virus (VSV): release of unusual particles with low infectivity.
    Maheshwari RK; Friedman RM
    Virology; 1980 Mar; 101(2):399-407. PubMed ID: 6244697
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of vesicular stomatitis virus mRNA synthesis by human MxA protein.
    Staeheli P; Pavlovic J
    J Virol; 1991 Aug; 65(8):4498-501. PubMed ID: 1649344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virus replication in enucleate cells: vesicular stomatitis virus and influenza virus.
    Follett EA; Pringle CR; Wunner WH; Skehel JJ
    J Virol; 1974 Feb; 13(2):394-9. PubMed ID: 4359299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of cicloxolone sodium on the replication of vesicular stomatitis virus in BSC-1 cells.
    Dargan DJ; Galt CB; Subak-Sharpe JH
    J Gen Virol; 1992 Feb; 73 ( Pt 2)():397-406. PubMed ID: 1311361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of vesicular stomatitis virus by kethoxal bis (thiosemicarbazone).
    Levinson W; Oppermann H; Jackson J
    J Gen Virol; 1977 Oct; 37(1):183-90. PubMed ID: 72131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.